Severity: 8192
Message: ini_set(): session.sid_length INI setting is deprecated
Filename: Session/Session.php
Line Number: 390
Backtrace:
File: /home/vjfarma/public_html/application/controllers/PagesController.php
Line: 10
Function: __construct
File: /home/vjfarma/public_html/index.php
Line: 315
Function: require_once
Severity: Warning
Message: session_set_save_handler(): Session save handler cannot be changed after headers have already been sent
Filename: Session/Session.php
Line Number: 110
Backtrace:
File: /home/vjfarma/public_html/application/controllers/PagesController.php
Line: 10
Function: __construct
File: /home/vjfarma/public_html/index.php
Line: 315
Function: require_once
Severity: Warning
Message: session_start(): Session cannot be started after headers have already been sent
Filename: Session/Session.php
Line Number: 143
Backtrace:
File: /home/vjfarma/public_html/application/controllers/PagesController.php
Line: 10
Function: __construct
File: /home/vjfarma/public_html/index.php
Line: 315
Function: require_once
| PRODUCT NAME | COA | DMF | GMP | WHO GMP | USFDA | CEP | WC | EUGMP |
|---|---|---|---|---|---|---|---|---|
| ANTI CANCER | ||||||||
| Abiraterone Acetate |
|
|
|
|
|
|
|
|
| Anastrazole |
|
|
|
|
|
In process
|
|
|
| Azacitadine |
|
|
|
|
|
|
|
|
| Bicalutamide |
|
|
|
|
|
In process
|
|
|
| Bortezomib |
|
|
|
|
|
In process
|
|
|
| Busulfan |
|
|
|
|
|
In process
|
|
|
| Capacitabine |
|
|
|
|
|
In process
|
|
|
| Carboplatin |
|
|
|
|
|
In process
|
|
|
| Cyclophosphamide |
|
|
|
|
|
In process
|
|
|
| Cytarabine |
|
|
|
|
|
In process
|
|
|
| Dasatinib |
|
|
|
|
|
In process
|
|
|
| Erlotinib |
|
|
|
|
|
In process
|
|
|
| Gefitinib |
|
|
|
|
|
In process
|
|
|
| Gemcitabine |
|
|
|
|
|
In process
|
|
|
| Imatinib |
|
|
|
|
|
|
|
|
| Irinotecan HCL |
|
|
|
|
|
|
|
|
| Letrozole |
|
|
|
|
|
In process
|
|
|
| Lapatinib |
|
|
|
|
|
|
|
|
| Mitomycin |
|
|
|
|
|
|
|
|
| Oxaliplatin |
|
|
|
|
|
|
|
|
| Sorafenib |
|
|
|
|
|
In process
|
|
|
| Temozolamide |
|
|
|
|
|
In process
|
|
|
| ANTI BIOTIC | ||||||||
| Mupirocin |
|
|
|
|
|
|
|
|
| Fusidic Acid |
|
|
|
|
|
|
|
|
| Rifampicin |
|
|
|
|
|
|
|
|
| Sirolimus |
|
|
|
|
|
|
|
|
| Teicoplanin |
|
|
|
|
|
|
|
|
| Vancomycin HCL |
|
|
|
|
|
|
|
|
| ANTI FUNGAL | ||||||||
| Caspofungin |
|
|
|
|
|
|
|
|
| Anidulafungin |
|
|
|
|
|
|
|
|
| Micafungin |
|
|
|
|
|
|
|
|
| Rezafungin |
|
|
|
|
|
|
|
|
| ANTI COAGULANT | ||||||||
| Heparin Sodium |
|
|
|
|
|
|
|
|
| Low Grade Glycosaminoglycans (LGG) |
|
|
|
|
|
|
|
|
| Enoxaparin Sodium |
|
|
|
|
|
|
|
|
| ANTI DIABETIC | ||||||||
| Dapagliflozin |
|
|
|
|
|
|
|
|
| Empagliflozin |
|
|
|
|
|
|
|
|
| IMMUNOSUPRASANT | ||||||||
| Cyclosporine |
|
|
|
|
|
|
|
|
| Everolimus |
|
|
|
|
|
|
|
|
| Mycophenolate Sodium |
|
|
|
|
|
|
|
|
| Mycophenolate Mofetil |
|
|
|
|
|
|
|
|
| Sirolimus |
|
|
|
|
|
|
|
|
| Tacrolimus |
|
|
|
|
|
|
|
|
| STERIOD HORMONE | ||||||||
| Dydrogesterone |
|
|
|
|
|
|
|
|
| Progesterone |
|
|
|
|
|
|
|
|
| HEPATOBILIARY | ||||||||
| Urodeoxycholic Acid (UDCA) |
|
|
|
|
|
|
|
|
| Chenodeoxycholic Acid (CDCA) |
|
|
|
|
|
|
|
|
| 7-ketolithocholic Acid (7KLCA) |
|
|
|
|
|
|
|
|
| OTHERS | ||||||||
| Erythropoietin |
|
|
|
|
|
|
|
|
| PRODUCT NAME | CAS NO. | SPECIFICATION | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTI CANCER | ||||||||
| Sunitinib | 557795-19-4 | IHS | ||||||
| Afatinib | 850140-72-6 | IHS | ||||||
| Axitinib | 319460-85-0 | IHS | ||||||
| Bendamustine HCl | 3543-75-7 | IP | ||||||
| Cisplatin | 15663-27-1 | USP/BP/IP | ||||||
| Carfilozomib | 868540-17-4 | IHS | ||||||
| Decitabine | 2353-33-5 | IHS | ||||||
| Methotrexate. | 59-05-2 | USP/BP/IP | ||||||
| Doxorubicin HCl | 25316-40-9 | USP/BP/IP | ||||||
| Enzalutamide | 915087-33-1 | IHS | ||||||
| Epirubicin HCl | 56390-09-1 | USP/BP | ||||||
| Etoposide | 33419-42-0 | USP/BP/IP | ||||||
| Exemestane | 107868-30-4 | USP/BP/IP | ||||||
| Lapatinib | 388082-78-8 | IP | ||||||
| Lenalidomide | 191732-72-6 | IHS | ||||||
| Pazopanib HCl | 635702-64-6 | IHS | ||||||
| Tamoxifen Citrate | 54965-24-1 | USP/BP/IP | ||||||
| 5-Fluorouracil | 17902-23-7 | IP | ||||||
| Paclitaxel | 33069-62-4 | USP | ||||||
| Pazopanib HCl | 635702-64-6 | IHS | ||||||
| Pemetrexed Disodium Heptahydrate | 357166-29-1 | USP/BP/IP | ||||||
| PRODUCT NAME | COA | DMF | GMP | EUGMP | USFDA | CEP | WC |
|---|---|---|---|---|---|---|---|
| Antibiotics | |||||||
| Ceftriaxone Sodium |
|
|
|
|
|
|
|
| Meropenem/Sterile |
|
|
|
|
|
|
|
| Meropenem With Sodium Carbonate |
|
|
|
|
|
|
|
| Aztreonam/Aztreonam Arginine |
|
|
|
|
|
|
|
| Fusidic Acid |
|
|
|
|
|
|
|
| Sodium Fusidate |
|
|
|
|
|
|
|
| Azithromycin |
|
|
|
|
|
|
|
| Azithromycin |
|
|
|
|
|
|
|
| Avibactam Sodium |
|
|
|
|
|
|
|
| Cefotaxime Sodium |
|
|
|
|
|
|
|
| Ceftizoxime Sodium |
|
|
|
|
|
|
|
| Vancomycin Hydrochloride |
|
|
|
|
|
|
|
| Bacitracin Zinc |
|
|
|
|
|
|
|
| Polymyxin B Sulfate |
|
|
|
|
|
|
|
| Polymyxin B Sulfate |
|
|
|
|
|
|
|
| Streptomycin Sulfate |
|
|
|
|
|
|
|
| Clindamycin Phosphate |
|
|
|
|
|
|
|
| Procaine Penicillin G |
|
|
|
|
|
|
|
| Sulfadoxine |
|
|
|
|
|
|
|
| Cardiovascular | |||||||
| Noradrenaline Bitartrate |
|
|
|
|
|
|
|
| Rocuronium Bromide |
|
|
|
|
|
|
|
| Heparin Sodium |
|
|
|
|
|
|
|
| Enoxaparin Sodium |
|
|
|
|
|
|
|
| Nadroparin Calcium |
|
|
|
|
|
|
|
| Low Grade Glycosaminoglycans |
|
|
|
|
|
|
|
| Steroids | |||||||
| Megestrol Acetate |
|
|
|
|
|
|
|
| Medroxyprogesterone Acetate |
|
|
|
|
|
|
|
| Dydrogesterone |
|
|
|
|
|
|
|
| Abiraterone Acetate |
|
|
|
|
|
|
|
| Mifepristone |
|
|
|
|
|
|
|
| Deflazacort |
|
|
|
|
|
|
|
| Anticancer | |||||||
| DHEA |
|
|
|
|
|
|
|
| Paclitaxel |
|
|
|
|
|
|
|
| Docetaxel |
|
|
|
|
|
|
|
| Carboplatin |
|
|
|
|
|
|
|
| Cisplatin |
|
|
|
|
|
|
|
| Oxaliplatin |
|
|
|
|
|
|
|
| Fulvestrant |
|
|
|
|
|
|
|
| Flumazenil |
|
|
|
|
|
|
|
| Fludarabine Phosphate |
|
|
|
|
|
|
|
| Peptides | |||||||
| Terlipressin Acetate |
|
|
|
|
|
|
|
| Octreotide Acetate |
|
|
|
|
|
|
|
| Semaglutide |
|
|
|
|
|
|
|
| Liraglutide |
|
|
|
|
|
|
|
| Aprotinin |
|
|
|
|
|
|
|
| HCG |
|
|
|
|
|
|
|
| Urokinase |
|
|
|
|
|
|
|
| Ulinastatin |
|
|
|
|
|
|
|
| Hypoglycins | |||||||
| Empagliflozin |
|
|
|
|
|
|
|
| Dapagliflozin |
|
|
|
|
|
|
|
| Teneligliptin |
|
|
|
|
|
|
|
| Sitagliptin Phosphate Monohydrate |
|
|
|
|
|
|
|
| Vitamin D Group | |||||||
| Paricalcitol |
|
|
|
|
|
|
|
| Calcidiol/calcifediol |
|
|
|
|
|
|
|
| Calcitriol |
|
|
|
|
|
|
|
| Alfacalcidol |
|
|
|
|
|
|
|
| Vitamin D2/D3 |
|
|
|
|
|
|
|
| Immunosuppressor | |||||||
| Tacrolimus |
|
|
|
|
|
|
|
| Rapamycin |
|
|
|
|
|
|
|
| Everolimus |
|
|
|
|
|
|
|
| Pimecrolimus |
|
|
|
|
|
|
|
| Hepatobiliary Drugs | |||||||
| Urodeoxycholic Acid(UDCA) |
|
|
|
|
|
|
|
| Ornithine Aspartate;LOLA |
|
|
|
|
|
|
|
| Glutathione; GSH |
|
|
|
|
|
|
|
| L- Carnitine |
|
|
|
|
|
|
|
| Others | |||||||
| Diosmin |
|
|
|
|
|
|
|
| Rutin |
|
|
|
|
|
|
|
| Tranexamic Acid |
|
|
|
|
|
|
|
| Procaine Hydrochloride |
|
|
|
|
|
|
|
| Propofol |
|
|
|
|
|
|
|
| PRODUCT NAME | COA | DMF (Total) | BIOSIMILARITY REPORT | STABILITY REPORT | MOA | PFD |
|---|---|---|---|---|---|---|
| Pembrolizumab |
|
|
|
|
|
|
| Nivolumab |
|
|
|
|
|
|
| Trastuzumab |
|
|
|
|
|
|
| Tocilizumab |
|
|
|
|
|
|
| Denosumab |
|
|
|
|
|
|
| Dupilumab |
|
|
|
|
|
|
| Tezepelumab |
|
|
|
|
|
|
| Supaglutide |
|
|
|
|
|
|
| Alirocumab |
|
|
|
|
|
|
| Secukinumab |
|
|
|
|
|
|
| Faricimab |
|
|
|
|
|
|
| Romosozumab |
|
|
|
|
|
|
| Aflibercept |
|
|
|
|
|
|
| Cetuximab |
|
|
|
|
|
|
| Rituximab |
|
|
|
|
|
|
| Bevacizumab |
|
|
|
|
|
|
| Adalimumab |
|
|
|
|
|
|
| Atezolizumab |
|
|
|
|
|
|
| Dulaglutide |
|
|
|
|
|
|
| Eculizumab |
|
|
|
|
|
|
| Omalizumab |
|
|
|
|
|
|
| Pertuzumab |
|
|
|
|
|
|
| Daratumumab |
|
|
|
|
|
|
| Iceanemab |
|
|
|
|
|
|
| Ipilimumab |
|
|
|
|
|
|
| Aducanumab |
|
|
|
|
|
|
| Evolocumab |
|
|
|
|
|
|
| Infliximab |
|
|
|
|
|
|
| Ramucirumab |
|
|
|
|
|
|
| Ustekinumab |
|
|
|
|
|
|
| Vedolizumab |
|
|
|
|
|
|
| Natalizumab |
|
|
|
|
|
|
| Panitumumab |
|
|
|
|
|
|
| Mepolizumab |
|
|
|
|
|
|
| Alemtuzumab |
|
|
|
|
|
|
| Dupliumab |
|
|
|
|
|
|
| Emicizumab |
|
|
|
|
|
|
| Ocrelizumab |
|
|
|
|
|
|
| Risankizumab |
|
|
|
|
|
|
| Casirivimab |
|
|
|
|
|
|
| Imdevimab |
|
|
|
|
|
|
| Benralizumab |
|
|
|
|
|
|
| Lecanemab |
|
|
|
|
|
|
| PRODUCT NAME | INTERMEDIATE NAME | CAS NO. |
|---|---|---|
|
Abrocitinib
|
Carbamic Acid,N-[cis-3-(methylamino)cyclobutyl]- Phenylmethyl Ester | 1353501-22-0 |
| Carbamic Acid,N-[cis-3-(methylamino)cyclobutyl]- Phenylmethyl Ester Hydrochloride | 2204290-99-1 | |
| 3-Oxocyclobutanecarboxylic Acid | 23761-23-1 | |
|
Abiraterone Acetate
|
DHEA | 53-43-0 |
| DHEA Iodine | 32138-69-5 | |
| Borane | 89878-14-8 | |
|
Acalabrutinib
|
[4-(2-pyridylcarbamoyl)phenyl]boronic Acid | 850568-25-1 |
| 3-Chloropyrazin-2-yl)MethanaMine Hydrochloride | 939412-86-9 | |
| N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2- Dioxaborolan-2-yl)benzamide | 1383385-64-5 | |
| (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin- 3-yl)pyrrolidine-1-carboxylate | 1420478-88-1 | |
| (3-chloropyrazin-2-yl)methanamine Hydrochloride | 867165-53-5 | |
|
Adagrasib
|
1-Bromo-8-chloronaphthalene | 20816-79-9 |
| Tert-Butyl 2,4-dichloro-5,6,7,8-tetrahydropyrido[3, 4-d]pyrimidine-7-carboxylate | 916420-27-4 | |
| 2-Propenoic Acid, 2-fluoro-, Sodium Salt | 74893-46-2 | |
| (R)-1-Boc-3-hydroxymethylpiperazine | 278788-66-2 | |
|
Apalutamide
|
Fragment A | 915087-25-1 |
| Fragment B | 951753-87-0 | |
| Fragment C | 573762-62-6 | |
|
Asciminib
|
(R)-3-Hydroxypyrrolidine | 2799-21-5 |
| 5-Bromo-6-chloronicotinic Acid | 29241-62-1 | |
| 1-(Tetrahydropyran-2-yl)-1H-pyrazole-5- Boronic Acid Pinacol Ester | 903550-26-5 | |
|
Atogepant
|
(S)-2'-Oxo-1',2',5,7- Tetrahydrospiro[cyclopenta[b]pyridine-6,3'- Pyrrolo[2,3-b]pyridine]-3-carboxylic Acid | 1375541-21-1 |
| Tert-butyl ((3S,5S,6R)-6-methyl-2-oxo-5-(2,3,6- Trifluorophenyl)piperidin-3-yl)carbamate | 1456803-43-2 | |
|
Avapritinib
|
6-Bromo-4-chloropyrrolo[2,1-f][1,2,4]triazine | 916420-30-9 |
| 6-Bromopyrrolo[2,1-f][1,2,4]triazin-4(1H)-one | 888721-83-3 | |
| Tert-butyl 4-[5-(4-fluorobenzoyl)pyrimidin-2- Yl]piperazine-1-carboxylate | 1703794-73-3 | |
| (4-fluorophenyl)[2-(1-piperazinyl)-5-pyrimidinyl]- Methanone Hydrochloride | 1703795-52-1 | |
| 6-(1-Methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4] Triazin- 4(1H)-one | 1703794-32-4 | |
| 4-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- F][1,2,4]triazine | 1703794-33-5 | |
|
Belzutifan
|
3-Fluoro-5-((7-(methylsulfonyl)-1-oxo-2,3-dihydro- 1H- Inden-4-yl)oxy)benzonitrile | 1672665-55-2 |
|
Bosutinib
|
N2 | 380844-49-5 |
| Fragment A | 98446-49-2 | |
|
Belumosudil
|
2-bromo-N-isopropylacetamide | 75726-96-4 |
| 1-Boc-5-aminoindazole | 129488-10-4 | |
| Phenol, 3-(4-chloro-2-quinazolinyl)-, 1-acetate | 911417-24-8 | |
| N-2 | 911417-26-0 | |
|
Cannabidiol
|
(1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol | 22972-51-6 |
| Methyl 2,4-dihydroxy-6-pentylbenzoate | 58016-28-7 | |
| Olivetol | 500-66-3 | |
|
Carfilzomib
|
N2 | 247068-82-2 |
| N1 | 247068-85-5 | |
|
Ceritinib
|
Fragment A | 1032903-50-6 |
| Fragment B | 761440-16-8 | |
|
Cenicriviroc
|
4-(2-Butoxyethoxy)phenylboronic Acid | 279262-28-1 |
| 4-[[(1-Propyl-1H-imidazol-5- Yl)methyl]thio]benzenamine | 597583-17-0 | |
| 8-Bromo-1,2,3,4-tetrahydro-1-(2-methyl Propyl)-1-benzazocine-5-carboxylic Acid | 597583-12-5 | |
| (S)-4-[[(1-Propylimidazol-5-yl)methyl]sulfinyl]aniline | 497223-38-8 | |
|
Cenobamate
|
(R)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethanol | 1259059-77-2 |
| 1-(2-chlorophenyl)-2-(1,2,3,4-tetrazol-2-yl)ethan-1-one | 1259059-71-6 | |
| Oxirane, (2-chlorophenyl)-, (2R)- | 62566-66-9 | |
|
Darolutamide
|
5-Acetyl-1H-Pyrazole-3-Carboxylic Acid | 1297537-45-1 |
| 4-bromo-2-chlorobenzonitrile | 903550-26-5 | |
| 1-tetrahydropyran-1H-pyrazolylboronic Ester | 154607-01-9 | |
| 2-Chloro-4-(1H-pyrazol-3-yl)benzonitrile | 1297537-37-1 | |
| (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2- Chlorobenzonitrile | 1297537-41-7 | |
|
Dapagliflozin
|
Dapagliflozin Tetraacetate | 461432-25-7 |
|
Deucravacitinib
|
3-pyridazinecarboxylic Acid, 4,6-dichloro-, Lithium Salt,hydrate | 2245111-15-1 |
| 2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3- Yl)benzenamine | 1609394-10-6 | |
| Ethyl 1,6-dihydro-4-hydroxy-6-oxo-3- Pyridazinecarboxylate | 1352925-63-3 | |
|
Dunuglipron
|
Methyl (S)-2-(Chloromethyl)-1-(2-oxetanylmethyl) -1H- Benzo[d]imidazole-6-carboxylate | 2230200-76-5 |
| 3-fluoro-4-(((6-(piperidin-4-yl)pyridin-2-yl )oxy)methyl)benzonitrile Bis(4-methyl Benzenesulfonate) | 2230200-25-4 | |
|
Drospirenone
|
N2 | 82543-16-6 |
|
Eplerenone
|
Fragment A | 192569-17-8 |
| N2 | 95716-70-4 | |
|
Empagliflozin
|
Acetoxy Empagliflozin | 915095-99-7 |
| 5-Bromo-2-chlorobenzoic Acid | 21739-92-4 | |
|
Erythromycin Thiocyanate
|
NA | 7704-67-8 |
|
ECC5004
|
(S)-3-(1-cyanocyclopropyl)-7-(2,2-dimethyltetrahydro- 2H-pyran-4-yl)indolizine-2-carboxylic Acid | 2758661-32-2 |
| 5-bromo-4-fluoro-1-methyl-1H-indazole | 1784678-61-0 | |
| Tert-butyl (S)-3-amino-2-(3-cyclopropyl-4-fluorophenyl)- 4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine- 5-carboxylate | NA | |
| Tert-butyl (S)-2-(3-cyclopropyl-4-fluorophenyl)-4-methyl- 3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7- Tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate | NA | |
| (3-cyclopropyl-4-fluorophenyl)hydrazine | 2758662-19-8 | |
| Tert-butyl (2S)-3-cyano-2-methyl-4-oxopiperidine-1- Carboxylate | 2212021-56-0 | |
| 5-bromo-4-fluoro-1-methyl-1H-indazole | 1784678-61-0 | |
|
Eribulin
|
EA | 871360-09-7 |
| EB | 157322-47-9 | |
| EC | 1808153-90-3 | |
| EB+C | 253128-10-8 | |
|
Fesoterodine
|
N2 | 207679-81-0 |
|
Filgotinib
|
5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine | 1010120-55-4 |
| Cyclopropanecarboxylic Acid (5-bromo- [1,2,4]triazolo[1,5-a]pyridin-2-yl)amide | 1142943-96-1 | |
| 5-chloro-[1,2,4]triazolo[1,5-a]pyridin-2-amine | 175965-64-7 | |
| 2-(4-(Bromomethyl)phenyl)-4,4,5,5-tetramethyl- 1,3,2-dioxaborolane | 138500-85-3 | |
| Thiomorpholine 1,1-Dioxide Hydrochloride | 59801-62-6 | |
| 4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)- Benzyl]-thiomorpholine-1,1-dioxide | 1092563-25-1 | |
|
Finerenone
|
4-Amino-5-methyl-2(1H)-pyridinone | 95306-64-2 |
| 2-Methoxy-4-cyanobenzaldehyde | 21962-45-8 | |
| (Z)-2-cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate | 1050477-39-8 | |
|
Fezolinetant
|
(R)-3-methyl-2-ketopiperazine | 922178-61-8 |
| 3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | 1375066-73-1 | |
|
Fulvestrant
|
N2 | 875573-69-6 |
|
Gemcitabine
|
T6 | 122111-01-7 |
| T8 | 122111-11-9 | |
|
Isavuconazonium Sulfate
|
2-(methylamino)pyridin-3-yl)methyl 2-((tertbutoxycarbonyl)(methyl)amino)acetate | 1180002-01-0 |
| (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl- 4-(1H-1,2,4-triazol-1-yl)thiobutyraMide | 368421-58-3 | |
| (2-(((1-Chloroethoxy)carbonyl)(methyl)amino)pyridin-3- Yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate | 338990-31-1 | |
|
Ibrutinib
|
Fragment A | 330786-24-8 |
| Fragment A | 143900-44-1 | |
|
Iptacopan
|
Benzyl (2S,4S)-4-ethoxy-2-(4-(methoxycarbonyl) Phenyl)piperidine-1-carboxylate | 1644667-60-6 |
| 4-((2S,4S)-1-((benzyloxy)carbonyl)-4- Ethoxypiperidin-2-yl)benzoic Acid | 1644667-59-3 | |
| Benzyl (2S,4S)-2-(4-cyanophenyl)-4-ethoxypiperidine-1-carboxylate | 1644667-58-2 | |
| Benzyl (2S,4S)-2-(4-cyanophenyl)-4-hydroxypiperidine-1-carboxylate | 1644667-60-6 | |
| Tert-Butyl 4-formyl-5-methoxy-7-methyl- 1H-indole-1-carboxylate | 1481631-51-9 | |
| Methyl 4-[(2S,4S)-4-ethoxy-2-piperidinyl]benzoate | 1644667-61-7 | |
|
Lorlatinib
|
Fragment A | 1454847-96-1 |
| Fragment B | 1643141-20-1 | |
|
Lenvatinib
|
Fragment A | 417721-36-9 |
| Fragment B | 417717-20-5 | |
|
Lumateperone
|
(4aS,9bR)-6-bromo-1H,2H,3H,4H,4aH,5H, 9bH-pyrido[4,3-b]indole | 1059630-07-7 |
| 6-bromo-2,3,4,5-tetrahydro-1H-pyrido[4,3- B]indolehydrochloride | 1059630-11-3 | |
| Ethyl (4aS,9bR)-6-bromo-5-(2-(methylamino)-2- Oxoethyl)-1,3,4,4a,5,9b-hexahydro-2H-pyrido[4,3- B]indole-2-carboxylate | 2098497-32-4 | |
|
Lenacapavir
|
4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- Yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine | 2189684-53-3 |
| 2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5- Tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol- 1-yl)acetic Acid | 1620056-83-8 | |
| Carbamic Acid,N-[(1S)-1-[3-bromo-6-[3-methyl-3- (methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5- Difluorophenyl)ethyl]-,1,1-dimethylethyl Ester | 2189684-54-4 | |
| Tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5- Difluorophenyl)ethyl)carbamate | 1620056-47-4 | |
|
Lurbinectedin
|
Corey 16 | 265134-87-0 |
| Corey 21 | 182201-62-3 | |
|
Lapatinib
|
Fragment A | 104458-24-4 |
| Fragment B | 27329-70-0 | |
| Fragment C | 231278-20-9 | |
|
Mavacamten
|
Isopropylurea | 691-60-1 |
| 1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione | 69998-14-7 | |
| 6-Chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione | 887581-47-7 | |
|
Mirogabalin
|
3-Ethyl Bicyclo [3.2.0]hept-3-en-6-one | 1235479-59-0 |
| (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one | 1235479-61-4 | |
|
Maribavir
|
1,2,3,5-Tetra-O-Acetyl-Beta-L-Ribofuranose | 144490-03-9 |
| 2-Bromo-5,6-Dichlorobenzimidazole | 142356-40-9 | |
|
Milvexian
|
[(S)-tert-butyl 1-(4-chloropyridin-2-yl)but-3- Enylcarbamate] | 1329171-69-8 |
| 1-(difluoromethyl)-4-nitro-1H-pyrazole | 956477-64-8 | |
| (R)-2-methylbut-3-enoic Acid | 20626-49-7 | |
| 6-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1- Yl)phenyl]pyrimidin-4-ol | 1802430-55-2 | |
|
Orforglipron
|
5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-1-((1S,2S)- 2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3- Yl)cyclopropyl)-1H-indole-2-carboxylic Acid | 2212021-83-3 |
| Ethyl (S)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1Hindole-2-carboxylate | 2212021-77-5 | |
| Ethyl (R)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1Hindole-2-carboxylate | 2758661-69-5 | |
| Tert-butyl (S)-3-amino-2-(4-fluoro-3,5-dimethylphenyl)- 4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine- 5-carboxylate | 2212021-59-3 | |
| Tert-butyl (S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl- 3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7- Tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate | 2212021-61-7 | |
| Di-tert-butyl 1-(4-fluoro-3,5-dimethylphenyl)hydrazine- 1,2-dicarboxylate | 2212021-55-9 | |
| Tert-butyl (2S)-3-cyano-2-methyl-4-oxopiperidine-1- Carboxylate | 2212021-56-0 | |
|
Osimertinib
|
4-fluoro-2-Methoxy-5-nitroaniline | 1075705-01-9 |
| 3-(2-chloropyriMidin-4-yl)-1-Methylindole | 1032452-86-0 | |
| N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4- (4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2- Nitrobenzene-1,4-diamine | 1421372-67-9 | |
| N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1Hindol-3-yl)pyrimidin-2-amine | 1421372-94-2 | |
| N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4- (4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4- Triamine | 1421372-66-8 | |
|
Neratinib
|
Fragment A | 848133-76-6 |
| Fragment B | 524955-09-7 | |
|
Niraparib
|
Fragment A | 1171197-20-8 |
| Fragment B | 677304-69-7 | |
|
Nintedanib Ethanesulfonate Salt
|
Fragment A | 14192-26-8 |
| Fragment B | 1168150-46-6 | |
| Fragment C | 1139453-98-7 | |
|
Olaparib
|
N2 | 763114-25-6 |
|
Pazopanib
|
N2 | 635702-60-2 |
|
Pexidartinib
|
5-Chloro-1H-pyrrolo[2,3-b]pyridine | 866546-07-8 |
| 6-(Trifluoromethyl)-3-pyridinecarboxaldehyde | 386704-12-7 | |
| 5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3- Yl)methyl]-2-pyridinamine | 2040295-04-1 | |
|
Palbociclib
|
Tert-butyl 4-(6-aminopyridin-3- Yl)piperazine-1-carboxylate | 571188-59-5 |
| 6-bromo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3- D]pyrimidin-7(8H)-one | 1016636-76-2 | |
|
Pirtobrutinib
|
(1S)-2,2,2-trifluoro-1-methylethyl]hydrazine Hydrochloride | 2764851-03-6 |
| N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl] Methyl]-5-fluoro-2-methoxy-benzamide | 2764851-04-7 | |
|
Rimegepant
|
7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione | 39713-40-1 |
| (6S,9R)-6-(2,3-Difluorophenyl)-9-((triisopropylsilyl)oxy)- 6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-one | 1190363-46-2 | |
| (5S,6S,9R)-6-(2,3-difluorophenyl)-9- ((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5Hcyclohepta[b]pyridin-5-aminedihydrochloride | 1373116-04-1 | |
| 1,3-Dihydro-1-[1-(1H-imidazol-1-ylcarbonyl)-4- Piperidinyl]-2H-imidazo[4,5-b]pyridin-2-one | 1373116-06-3 | |
|
Ribociclib
|
2-Chloro-7-cyclopentyl-n,n-dimethyl-7h-pyrrolo[2,3d]pyrimidine-6-carboxamide | 1211443-61-6 |
| 2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]- Pyrimidine-6-carboxylic Acid | 1211443-58-1 | |
| 1-boc-4-(6-aminopyridin-3-yl)piperazine | 571188-59-5 | |
|
Rucaparib
|
8-Fluoro-1,3,4,5-tetrahydro-6H-pyrrolo[4,3,2- Ef][2]benzazepin-6-one | 1408282-26-7 |
| Fragment A | 283173-72-8 | |
| Fragment B | 1082040-43-4 | |
|
Roxadustat
|
5-phenoxyisobenzofuran-1(3H)-one | 57830-14-5 |
| Methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate | 1455091-10-7 | |
| Methyl 1,4-dihydroxy-7-phenoxyisoquinoline-3- Carboxylate | 1421312-32-4 | |
| Ethyl 1,4-dihydroxy-7-phenoxyisoquinoline-3-carboxylate | 2244489-54-9 | |
| 4-Hydroxy-1-methyl-7-phenoxy-3- Isoquinolinecarboxylic Acid Methyl Ester | 1421312-34-6 | |
|
Resmetirom
|
3,6-Dichloro-4-isopropylpyridazine | 107228-51-3 |
| 3,5-dichloro-4-((6-chloro-5-isopropylpyridazin- 3-yl)oxy)aniline | 920509-27-9 | |
| 6-(4-Amino-2,6-Dichlorophenoxy)-4- Isopropylpyridazin-3(2H)-One | 920509-28-0 | |
| N-Cyanoacetylurethane | 6629-04-5 | |
|
Ritlecitinib
|
(2S,5R)-Benzyl 5-amino-2-methylpiperidine-1- Carboxylate Hydrochloride | 1207853-23-3 |
| 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | 90213-66-4 | |
| Ritecitinib Intermediate | 2042650-70-2 | |
| 1-[(2S,5R)-2-Methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4- Ylamino)-1-piperidinyl]-2-propen-1-one Malonate | 1792180-81-4 | |
|
Sacubitril
|
(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tertbutoxycarbonyl)amino)-2-methylpentanoic Acid | 1012341-50-2 |
| (2R,4S)-4-Amino-5-(biphenyl-4-yl)-2-methylpentanoic Acid Ethyl Ester Hydrochloride | 149690-12-0 | |
|
Semaglutide Side Chain
|
Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH | 1662688-20-1 |
|
Selumetinib
|
O-(2-tert-butoxyethyl)hydroxylaMine | 1023742-13-3 |
| Methyl 6-((4-bromo-2-chlorophenyl)amino)- 7-fluoro-1H-benzo[d]imidazole-5-carboxylate | 606143-46-8 | |
| O-(2-(vinyloxy)ethyl)hydroxylamine | 391212-29-6 | |
|
Sotorasib
|
7-Chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin- 3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione | 2252403-82-8 |
| (S)-4-N-Boc-2-methylpiperazine | 147081-29-6 | |
| 2-isopropyl-4-methylpyridin-3-amine | 1698293-93-4 | |
| 2-Fluoro-6-methoxyphenylboronic Acid | 78495-63-3 | |
|
Sparsentan
|
3-Amino-4,5-dimethylisoxazole | 13999-39-8 |
| (2-(N-(4,5-dimethylisoxazol-3-yl)-N- (methoxymethyl)sulfamoyl)phenyl)boronic Acid | 415697-58-4 | |
| 2-bromo-N-(4,5-dimethylisoxazol-3- Yl)benzenesulfonamide | 195447-72-4 | |
| 2-bromo-N-(4,5-dimethylisoxazol-3-yl)-N- (methoxymethyl)benzenesulfonamide | 415697-57-3 | |
|
Sitagliptin
|
2,4,5-Trifluorophenylacetic Acid | 209995-38-0 |
| Boc-(R)-3-Amino-4-(2,4,5-Trifluorophenyl)-Butyric Acid | 486460-00-8 | |
| 3-(Trifluoromethyl)-5,6,7,8-tetrahydro- [1,2,4]triazolo[4,3-a]pyrazine Hydrochloride | 762240-92-6 | |
| Sitagliptin Base | 486460-32-6 | |
|
Talazoparib
|
Fragment A | 1620153-74-3 |
| Fragment B | 1322616-36-3 | |
|
Telotristat Etiprate LX 1606
|
Fragment A | 1033805-26-3 |
| N2 | 1033805-28-5 | |
|
Tegoprazan
|
R-5,7-Difluorochroman-4-ol | 1270294-05-7 |
| 1-benzyl-4-hydroxy-2-methyl-1Hbenzimidazole-6-carboxylic Acid | 1640981-19-6 | |
| 7-hydroxy-N,N,2-triMethyl-3-tosyl-3Hbenzo[d]iMidazole-5-carboxaMide | 942195-86-0 | |
|
Tofacitinib Citrate
|
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 |
| BAP-L-Tartrate | 477600-71-8 | |
|
Trilaciclib
|
5-(4-Methyl-1-piperazinyl)-2-pyridinamine | 571189-49-6 |
| Ethyl 2-(methylthio)-4-(3-oxo-1,4-diazaspiro- [5.5]undecan-1-yl)pyrimidine-5-carboxylate | 2170746-95-7 | |
| Spiro[cyclohexane-1,9'(6'H)-pyrazino- [1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)- Carboxylic Acid, 2'-(methylthio)-6'-oxo-, 1,1- Dimethylethyl Ester | 2170746-99-1 | |
|
Tirzepatide
|
Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH | 2460751-66-8 |
| 20-(tert-Butoxy)-20-oxoicosanoic Acid | 683239-16-9 | |
|
Ubrogepant
|
1-(1,1-Dimethylethyl)-1,3-dihydro-2Hpyrrolo[2,3-b]pyridin-2-one | 1455358-06-1 |
| Ubrogepant Intermediate | 1375541-21-1 | |
| (3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2- Trifluoroethyl)piperidine-3-aminium 4-nitrobenzoate | 1456803-37-4 | |
|
Upadacitinib
|
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1- Pyrrolidinecarboxylic Acid Phenylmethyl Ester | 1428243-26-8 |
| 5-Bromo-4,7-diazaindole | 875781-43-4 | |
|
Vibegron
|
(1R,2R)-2-amino-6-(4-nitrophenyl)-1- Phenylhex-5-yn-1-olhydrochloride | 1628836-08-7 |
| (6S)-4,6,7,8-tetrahydro-4-oxo-Pyrrolo[1,2- A]pyriMidine-6-carboxylic Acid | 1190392-22-3 | |
|
Venetoclax (ABT-199)
|
Fragment A | 1228780-72-0 |
| Fragment B | 1228779-96-1 | |
|
Vonoprazan
|
5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde | 881674-56-2 |
| Pyridine-3-sulfonyl Chloride | 16133-25-8 | |
|
Voxelotor
|
(2-Chloro-3-pyridinyl)methanol | 42330-59-6 |
| 3-Pyridinemethanol, 2-[1-(1-methylethyl)-1H-pyrazol- 5-yl]-, Hydrochloride (1:1) | 2245886-82-0 | |
| 2-hydroxy-6-(methoxymethoxy)benzaldehyde | 84290-49-3 | |
|
Zavegepant
|
1-(1-Methyl-4-piperidinyl)piperazine | 23995-88-2 |
| Methyl (2R)-2-amino-3-(7-methyl-1H-indazol- 5-yl)propanoate Dihydrochloride | 1414976-14-9 | |
| 3-(Piperidin-4-yl)quinolin-2(1H)-one Hydrochloride | 855778-84-6 | |
| Methyl 2-(phenylmethoxycarbonylamino)prop-2-enoate | 21149-17-7 | |
| Methyl (R)-2-(benzyloxycarbonylamino)-3-(7- Methyl-1H-indazol-5-yl)-propanoate | 85578-40-4 |